JACC
ABSTRACTS - ACCIS2002
March 6, 2002
Conclusions: trended
In this large
pilot experience,
rates of ischemic
lower with bivalirudin
than with heparin
may be the first antithrcmbctic
agent to uncouple
hemorrhagic
during
and bleeding
contemporary
suppression
events from
Reduction in Percutaneous
Leslie Cho. A. Michael Linccff, John A. Bittl. Eric J. Tcpol, Cleveland
Clinic Foundation,
Background: among
Female
patients
Methods:
Cleveland,
Ohio, Ocala Heart Institufe,
gender
undergoing
is a known
Within a randomized
to unfractionated
heparin
major hemorrhage Results:
(the Bivalirudin
were stratified
rhage - males:
enrolled.
(Table). Considering
bivalirudin
Trial), rates of ischemic
1367 (32.2%)
events and
patients were women.
with a 2.3-fold 144/1367
was associated
However,
a combined
Ipshiva
comparing
increased
(10.4%) (pc0.0001).
with a significant
this effect was most striking safety and efficacy endpoint
When strati-
reduction
among
in bleeding
female
patients
of death, MI, revasculariza-
bivalirudin
in adverse
_ 141/690 (20.4%) vs 69/697 (9.9%) (p~O.OOOl), and a 35%
relative risk reduction Conclusions: ischemic prominent
is associated
women.
may benefit if bivalirudin
(7.6%) (p
with a substantial
in both men and women.
among
with a 50% relative risk reduction
in men - 171/1461 (11.7%) vs Ill/l464
Bivalirudin
events
was associated
Compared
risk of major hemor-
tion. and major hemorrhage. events in wcmen
Such patients
reduction
but the improved with an increased
is used in place of unfractionated Major
Kurctobi,
in bleeding
and
safety profile is especially risk of bleeding
during
PCI
heparin.
Atsushi
Ohtani, Kazuhisa Backgrounds, patients
(4.5%) YS females:
arm, bivalirudin
of gender.
angioplasty
Angioplasty
bleeding
(PCI).
by gender.
was associated
131/2925
fied by treatment regardless
gender
intervention
clinical trial of coronary
of the 4312 patients
to males, female
coronary
Smoking, Thrombus, and Plaque in the Culprit Vessel In Patients With Acute Myocardlal Infarction: Angioscopic Findings
1054-13
Ocala, Florida.
potent risk factor for post-procedural
percutaneous
Habitual
thrombolytic
therapy.
ated in 62 patients ous coronary Furthermore,
divided
and the number
enrolled
patients
we investigated
Bivalirudin
P Value
Women
(I 07/690) 15.5%
(37/697)
5.3%
<0.@301
Men
(92/1461)
(39/1464)
2.7%
of plaque
smokers.
Cleveland, Background: agulation
A. Michael Linccff, Marco Roffi, Teresa Kaldus,
Recently,
direct thrombin
in percutaneous
coronary
inhibitors
clotting time (ACT), used for monitoring
heparin.
new point-of-care
assay has been developed
which specifically
measures
evaluated
the correlation
activity duirng and Pro-DM) patients
receiving
To test the accuracy
the DTI bivalirudin of bivalirudin
and non-titrated Results:
for patients inhibitors.
of available
higher, and the prevalence
lower in smoking
association
of smoking
at The Cleveland concentration
Bivalirudin
concentration
time (ECT),
No prior study has of anti Factor Ila PCI
point of care
correlated
were tested in both
was calculated well
with
between
ECT
by the Spearman sample
bivalirudin
(rxO.76,
concentra-
ACT (r=0.26, p=O.O5) or pro-DM ACT (wO.41, p
alsc poor correlation
between
ECT and Hemcchrcn
Hemwhron
ACT (w0.40.
coagulation
in patients
din concentration.
Additionally
patients. These findings tion during
p=O.O02). Conclusion:
receiving
PCI with DTI.
ACT (r&27.
There was poor correlation bivalirudin,
pro-DM
ECT is a reliable measurement
while ACT has poor correlation
there is poor correlation
have important
p=O.O4) and ECT with
between
implications
between
for guiding
Tani, lkuyoshi
Matsumcto,
Takeo Anazawa,
Watanabe,
ACT and
Investigators
dence of acute coronary circulating
(50% vs. 35, p
This is first evidence
was
to assess the
in culprit lesion directly, and
Takeshi Fujii, Kazutoshi
Takashi Miyamoto,
paradox.
syndrome(ACS)
formation MDA-LDL
.Therefcre between
were collected
of left coronary analyses
Surugadai
Hospital,
with diffuse
LDL(MDA-LDL)
we investigated
the differences
of vascspasm
of spasm lesions were evaluated
was reponed
sinus
just at the lesion with focal vascspasm disease,
existed
diffusely
Plasma
MDA-LDL
along
circulation
% plaque volume
the mechanism
arteries.
levels associated
vated in the coronary increased
the coronary
in diffuse
thrombosis
in focal vascspasm.
intimal
of
thickness
in TableConclusions: were
significantly
Under this condition,
during focal vascccnstriction
of thrcmbogenicity
and volumetric More abundant
even in the absence
vascspasm,
Data is presented
with triggering
and Blood
before provocation
IVUS system.
soft plaque was localized
whereas
and Results:
IVUS study was performed
with Netra-3D
Recently to activate
in plaque appearance
significant
angiographic
has a high inci-
vascspasm.
.Methcds
and coronary
After relief of spasm,
Tokyo, Japan.
focal vascspasm
oxidized
two patterns
Michiaki
Tokyo, Japan, 2nd
School of Medicine,
compared
from aortic rcct(Ao)
spasm
Ishikawa,
Ken Nagao, Katsuo Kanmatsuse,
have that demonstrated
malondialdehyde-modified
thrombus samples
risk factors,
(136 vs. 114 mg/dl. ~~0.05)
Possible Mechanism of Coronary Thrombosis Caused by Vasospasm In Angiographically Nearly Normal Coronary Artery: Evaluation by Plaque Appearance and Malondlaldehyde-Modified Oxidized LDL
&&masa
plasma
in culprit lesion (2.7kO.9
of the smoker’s
Background:
DTI. A
with non-smok-
status. As ccronaly
of thrcmbus
receiving
64 consecutive
in body. Samples
coefficient
status and the amount
may provide the explanation
of Internal Medicine, Nihon University
tion and Hemcchrcn
ACT (r=O.52, p
compared
in IRA (3.012.0 vs. 3.3~1.6)
of hypertension
of Cardiobgy, Nihon University
Clinic. We compared
p
pro-DM
related artery was higher in
patients,
Conclusion.
Department
anti Factor Ila activity levels, Anti Factor Ila activity is
blood. Correlation
patients.
65% of the
(45% VS. 17%. p=O.O9). The
of plaque
by smoking
Department
ACT assays (Hemcchrcn
we enrolled
affected
for antico-
based on the ecarin clotting
and the rapid ECT assay (Pharmanetics),
a direct measurement test.
is uncertain
of ECT and ACT to the direct measurement
ACT and ECT to central laboratory titrated
(PCI). The accuracy
the activity of direct thrombin
PCI. Methods:
patients
in smoking
Results,
TIMI grade was not signifi-
vessels to infarcted
of the activated
(DTI) have been approved
interventions
baseline
with non- smoking
significantly
Kandice
Inc, Chapel Hi//, Ohio.
percutane-
after PCI were
lesion (4 grades from white to
artery (IRA).
(205 vs. 160 mg/dl, ~~0.05) and triglycelide
1054-14
The Cleveland Clinic Foundation,
Patrick D. Mize, David J. Moliterno.
Ohio, Pharrnanetics
Although
was higher prevalence
were significantly
A New Rapid Ecarin Clotting Time Assay but Not Activated Clotting Time Strongly Correlates With Blvallrudln Concentration: A Percutaneous Coronary Intervention Study Joel Reginelli,
an culprit
in infarct related
of collateral
compared
also these findings
Kottke-Marchant,
were underwent of thrombus
of
evalu-
1x33 or little: n=29) by angioscopy.
(massive:
the color of plaque
(65% vs. 22%, p
Total cholesterol
status is
The prevalence
arteries were successfully
max plaque score (2.7eO.9 vs. 2.7kO.9) and the color of plaque
Heparin
mCho,
that smoking
into 2 groups
prevalence
massive thrcmbus
in
successful
amount
vs. 2.6*1 .I) were not significantly
1053-5
the hypothesis
culprit lesion. Methods,
in the major coronary
prognosis
in the higher
(PCI), and the residual
were current
patients,
Tcmohito
with good
and results
(male: 55, mean age: 60.2). All patients
yellow),
Shimizu,
associated
(AMI),
of thrcmbus
of thrombus
we analyzed
cantly changed,
Ueda, Masahiko
is paradoxically infarction
Therefore,
intervention
semi-quantatively
smoking
smoking
with amount
and amount
Yasunori
Osaka Police Haspita/, Osaka, Japan.
myccardial
closely associated plaques
Hirayama,
Kodama,
with acute
ing patients
Hemorrhage
6.3%
SESSION
Sunday, March 17, 2002, 3:00 p.m.-5:OO p.m. Georgia World Congress Center, Hall G Presentation Hour: 3:00 p.m.-4:OO p.m.
Coronary Intervention-
Related Bleeding With Bivalirudin Is Particularly Striking in Women &s&&&v&,
17A
Cardiology)
Vulnerable Plaque: Acute lschemic Syndromes
1054
risk.
1053-4
& Interventional
POSTER
events
PCI. Bivalirudin
of ischemic
(Angiography
ele-
dramatically
might play an important
role in
leading to ACS
of antiDiffuse n=20
Focal n=l5
p value
-6.9+/-9.0
12+/-14.9
to.05
Vessel volume(mm3)
127.7+/-39.1
134.4+/s44.0
ns
Lumen volume(mm3)
91.3+/-11.2
79.5+/-10.6
ns
Plaque vclume(mm3)
30.6+/-10.2
55.2+/-10.3
<0.05
23.9+/-9.2
40.2+/-9.6
co.05
with bivaliru-
ACT and ECT in such
Cs-AC difference
of MDA-LDL
(U/L)
the extent of anticoagula-
% plaque volume(plaque
1054-I
volume)
Insulin Resistance as an Independent Predictor of Acute Coronary Syndrome: An Intravascular Ultrasound Study With Clinical Correlations
5
Takashi Yoshitama. Suguru
volume/vessel
Masato Nakamura.
Yajima, Masamichi
Hitoshi Anzai. Takahirc
Tan, Tsunoda,
Wada. Raisuke
Ycko Kitagawa,
lijima, Rintam
Nishida, Tetsu Yamaguchi,
Nakajima.
Ohashi Hospital,
Masanori
Shiba,
Takurc Takagi.
Jcho University,
Tokyo, Japan. Background:
Insulin
resistance
coronary
atherosclerosis.
coronary
syndrome
Methods: ultrasound
elastic membrane
asscciations
as an important
between
insulin
initiating
resistance
factor in and acute
(ACS) remain unclear.
Before intervention, (IVUS)
has been implicated
However,
examination
75 patients with 65 culprit lesions underwent by which cross-sectional
(EEM), lumen CSA, and plaque
intravascular
area (CSA) within the external
CSA were evaluated.
Positive remod-